Erratum: Generation of an efficiently secreted, cell penetrating NF-?B inhibitor (FASEB Journal (2014) 28 (373-381) DOI: 10.1096/fj.13-236570);Generation of an efficiently secreted, cell penetrating NF-κB inhibitor

FASEB Journal

Volumn 28, Issue 1, 2014, Pages 373-381

  Koutsokeras, Apostolos ^a   Purkayastha, Nirupam ^a   Rigby, Anne ^a   Subang, Maria C ^a   Sclanders, Michelle ^a   Vessillier, Sandrine ^a   Mullen, Lisa ^a   Chernajovsky, Yuti ^a   Gould, David ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Gene therapy; Inflammation; MMP; Protein transduction domain

Indexed keywords

HYBRID PROTEIN; I KAPPA B; INTERSTITIAL COLLAGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TRANSDUCTION DOMAIN;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CELLULAR SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN SECRETION; THERAPY EFFECT; CELL LINE; DRUG ANTAGONISM; GENE THERAPY; GENETICS; METABOLISM; METHODOLOGY; MMP;

GENE THERAPY; INFLAMMATION; MMP; PROTEIN TRANSDUCTION DOMAIN;

CELL LINE; GENETIC THERAPY; HUMANS; MATRIX METALLOPROTEINASE 1; NF-KAPPA B; RECOMBINANT FUSION PROTEINS;

EID: 84894572515     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-236570ERR     Document Type: Erratum

References (34)

1. Miagkov, A. V., Kovalenko, D. V., Brown, C. E., Didsbury, J. R., Cogswell, J. P., Stimpson, S. A., Baldwin, A. S., and Makarov, S. S. (1998) NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. U. S. A. 95, 13859-13864
2. Zhang, H. G., Huang, N., Liu, D., Bilbao, L., Zhang, X., Yang, P., Zhou, T., Curiel, D. T., and Mountz, J. D. (2000) Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Arthritis Rheum. 43, 1094-1105
3. Tomita, T., Takeuchi, E., Tomita, N., Morishita, R., Kaneko, M., Yamamoto, K., Nakase, T., Seki, H., Kato, K., Kaneda, Y., and Ochi, T. (1999) Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 42, 2532-2542
4. Kabouridis, P. S., Hasan, M., Newson, J., Gilroy, D. W., and Lawrence, T. (2002) Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha. J. Immunol. 169, 2587-2593
5. Blackwell, N. M., Sembi, P., Newson, J. S., Lawrence, T., Gilroy, D. W., and Kabouridis, P. S. (2004) Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum. 50, 2675-2684
6. May, M. J., D'Acquisto, F., Madge, L. A., Glockner, J., Pober, J. S., and Ghosh, S. (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289, 1550-1554
7. Di Meglio, P., Ianaro, A., and Ghosh, S. (2005) Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. Arthritis Rheum. 52, 951-958
8. Tas, S. W., Vervoordeldonk, M. J., Hajji, N., May, M. J., Ghosh, S., and Tak, P. P. (2006) Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. Arthritis Res. Ther. 8, R86
9. Rodriguez, M. S., Thompson, J., Hay, R. T., and Dargemont, C. (1999) Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J. Biol. Chem. 274, 9108-9115
10. Triantaphyllopoulos, K., Croxford, J., Baker, D., and Chernajovsky, Y. (1998) Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis. Gene Ther. 5, 253-263
11. Vessillier, S., Adams, G., and Chernajovsky, Y. (2004) Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3. Protein Eng. Des. Sel. 17, 829-835
12. de Rooij, J., and Bos, J. L. (1997) Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14, 623-625
13. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449-1452
14. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York
15. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
16. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267
17. Kulbe, H., Thompson, R., Wilson, J. L., Robinson, S., Hagemann, T., Fatah, R., Gould, D., Ayhan, A., and Balkwill, F. (2007) The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 67, 585-592
18. Adams, G., Vessillier, S., Dreja, H., and Chernajovsky, Y. (2003) Targeting cytokines to inflammation sites. Nat. Biotechnol. 21, 1314-1320
19. Vessillier, S., Adams, G., Montero-Melendez, T., Jones, R., Seed, M., Perretti, M., and Chernajovsky, Y. (2012) Molecular engineering of short half-life small peptides (VIP, alphaMSH and gamma3MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics. Ann. Rheum. Dis. 71, 143-149
20. Mullen, L., Adams, G., Foster, J., Vessillier, S., Koster, M., Hauser, H., Layward, L., Gould, D., and Chernajovsky, Y. (2013) A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints. [E-pub ahead of print] Ann. Rheum Dis. PMID: 23813971
21. Mullen, L., Rigby, A., Sclanders, M., Adams, G., Mittal, G., Colston, J., Fatah, R., Subang, C., Foster, J., Francis-West, P., Koster, M., Hauser, H., Layward, L., Vessillier, S., Annenkov, A., Al-Izki, S., Pryce, G., Bolton, C., Baker, D., Gould, D., and Chernajovsky, Y. (2013) Latency can be conferred to a variety of cytokines by fusion with latency associated peptide from TGF. Expert Opin. Drug Deliv. In press
22. Roomi, M. W., Monterrey, J. C., Kalinovsky, T., Rath, M., and Niedzwiecki, A. (2010) In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors. Oncol. Rep. 23, 605-614
23. Barka, T., Gresik, E. S., and Henderson, S. C. (2004) Production of cell lines secreting TAT fusion proteins. J. Histochem. Cytochem. 52, 469-477
24. Shaw, P. A., Catchpole, I. R., Goddard, C. A., and Colledge, W. H. (2008) Comparison of protein transduction domains in mediating cell delivery of a secreted CRE protein. Biochemistry 47, 1157-1166
25. Flinterman, M., Farzaneh, F., Habib, N., Malik, F., Gaken, J., and Tavassoli, M. (2009) Delivery of therapeutic proteins as secretable TAT fusion products. Mol. Ther. 17, 334-342
26. Koutsokeras, A., and Kabouridis, P. S. (2009) Secretion and uptake of TAT-fusion proteins produced by engineered mammalian cells. Biochim. Biophys. Acta 1790, 147-153
27. Shen, Y., Yu, W., Hay, J. G., and Sauthoff, H. (2011) Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity. Mol. Ther. 19, 903-912
28. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G., and Dowdy, S. F. (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477
29. Stripecke, R., Carmen Villacres, M., Skelton, D., Satake, N., Halene, S., and Kohn, D. (1999) Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 6, 1305-1312
30. Sachdev, S., Hoffmann, A., and Hannink, M. (1998) Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol. Cell. Biol. 18, 2524-2534
31. Turpin, P., Hay, R. T., and Dargemont, C. (1999) Characterization of IkappaBalpha nuclear import pathway. J. Biol. Chem. 274, 6804-6812
32. Schropfer, A., Kammerer, U., Kapp, M., Dietl, J., Feix, S., and Anacker, J. (2010) Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines. BMC Cancer 10, 553
33. Strickland, I., and Ghosh, S. (2006) Use of cell permeable NBD peptides for suppression of inflammation. Ann. Rheum Dis. 65(Suppl. 3), iii75-iii82
34. Lee, K. Y., D'Acquisto, F., Hayden, M. S., Shim, J. H., and Ghosh, S. (2005) PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 308, 114-118